Projects per year
Personal profile
Education
- 1978 Bachelor, Medical College, National Taiwan University
Experience
- 2018- Executive Director of Taiwan Association for Traditional and Complementary Medicine
- 2017- Director, Cancer Center of Taipei Municipal Wanfang Hospital Managed by Taipei Medical University
- 2017- Membership Promotion Committee Member of Taiwan Oncology Society
- 2017- Professor, College of Medicine, Taipei Medical University
- 2016- Deputy Chairman, Taiwan Nutraceutical Association
- 2015-2017 Supervisor, Human Biobank, Wan Fang Hospital, Taipei Medical University
- 2015-2017 Vice Superintendent, Wan Fang Hospital, Taipei Medical University
Awards
- 2018 Outstanding Research Grant Award of Taipei Medical University
- 2018 Excellent Research Grant Award of Taipei Medical University
- 2017 Excellent Research Grant Award of Taipei Medical University
- 2016 Travel Award, the 42nd Annual Meeting of Korean Cancer Association
- 2016 Excellent-Teacher Award of Taipei Medical University
- 2015 Kyorin Awards of Taipei Medical Association
- 2014 Travel Awards, the 40th Annual Meeting of Korean Cancer Association
- 2010 Kobayashi Foundation Awards at the 9th ACOS and the Awards ceremony
- 2007 Level 3 Awards for Science and Technology of Anhui Province
- 2007 Level 1 Awards for Science and Technology of Ho-Fei City
Research Interests
- In addition to the expertise in clinical trial, Dr. Lai’s researchinterests is to look for more efficacious cancer therapy by combining drugs or seeking active ingredients of natural products from which are regarding as Complementary and Alternative Medicine (CAM). Dr. Lai evaluates those candidates by examining their molecular targeting effects in the aspects of differentiation induction, cell cycle regulation, signal transduction inhibition, reversal of drug resistance, and chemoprevention.
Fingerprint
Dive into the research topics where Gi-Ming Lai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
α9-型尼古丁乙醯膽鹼受體在乳癌幹細胞的角色與防治藥物的篩選
8/1/13 → 7/31/14
Project: B - Project of TMU › i - Other (Funded by TMU)
Research output
-
Astragalus Polysaccharide (PG2) Suppresses Macrophage Migration Inhibitory Factor and Aggressiveness of Lung Adenocarcinoma Cells
Liao, C. H., Yong, C. Y., Lai, G. M., Chow, J. M., Cheng, C. F., Fang, C. L., Lin, P. C., Chang, C. L., Zheng, Y. M., Chuang, S. E., Whang-Peng, J. & Yao, C. J., 2020, (Accepted/In press) In: American Journal of Chinese Medicine. 48, 6, p. 1491-1509 19 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Omega-3 Fatty Acid-Enriched Fish Oil and Selenium Combination Modulates Endoplasmic Reticulum Stress Response Elements and Reverses Acquired Gefitinib Resistance in HCC827 Lung Adenocarcinoma Cells
Liao, C. H., Tzeng, Y. T., Lai, G. M., Chang, C. L., Hu, M. H., Tsai, W. L., Liu, Y. R., Hsia, S., Chuang, S. E., Chiou, T. J., Wang, L. M., Whang-Peng, J. & Yao, C. J., Jul 29 2020, In: Marine Drugs. 18, 8, 399.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Subcutaneous Panniculitis Like T Cell Lymphoma Complicated With Hemophagocytic Lymphohistiocytosis - A Challenging Case Report
Zheng, Y. M., Chang, C., Hu, M-H., Chao, H-M., Whang-Peng, J., Lai, G-M. & Chiou, T-J., Jan 1 2020, In: Archives of Clinical and Medical Case Reports. 04Research output: Contribution to journal › Article › peer-review
-
Electrospun polylactic acid (PLLA) microtube array membrane (MTAM)-An advanced substrate for anticancer drug screening
Tseng, C. H., Huang, W. T., Chew, C. H., Lai, J. K., Tu, S. H., Wei, P. L., Lee, K. Y., Lai, G. M. & Chen, C. C., Feb 14 2019, In: Materials. 12, 4, 569.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
Epigenetic modification and differentiation induction of malignant glioma cells by oligo-fucoidan
Liao, C. H., Lai, I. C., Kuo, H. C., Chuang, S. E., Lee, H. L., Whang-Peng, J., Yao, C. J. & Lai, G. M., Sep 8 2019, In: Marine Drugs. 17, 9, 525.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus)
Datasets
-
Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, Nov 15 2017
DOI: 10.6084/m9.figshare.c.3931717.v1, https://figshare.com/collections/Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/3931717/1
Dataset
-
Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction
Huang, J. (Contributor), Yao, C. (Contributor), Chuang, S. (Contributor), Yeh, C. (Contributor), Lee, L. (Contributor), Chen, R. (Contributor), Chao, W. (Contributor), Whang-Peng, J. (Contributor) & Lai, G. (Contributor), Unknown Publisher, Mar 24 2016
DOI: 10.6084/m9.figshare.c.3643112.v1, https://figshare.com/collections/Honokiol_inhibits_sphere_formation_and_xenograft_growth_of_oral_cancer_side_population_cells_accompanied_with_JAK_STAT_signaling_pathway_suppression_and_apoptosis_induction/3643112/1
Dataset
-
MOESM1 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, Nov 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d1.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM1_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606626/1
Dataset
-
MOESM2 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, Nov 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d2.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM2_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606662/1
Dataset
-
MOESM3 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, Nov 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d3.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM3_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606698/1
Dataset